Usv Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
One of their notable products is DOLASETRON MESYLATE USP, with a corresponding US DMF Number 33211.
Remarkably, this DMF maintains an Active status since its submission on September 28, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 14, 2020, and payment made on September 26, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II